Introduction: Osteoporosis is characterized by decreased bone mineral density (BMD) and is a risk factor for hip, wrist, and vertebral fractures. Fragility fractures lead to increased mortality, morbidity, pain, immobility, social isolation and depression, which all may affect the quality of life (QoL). Use of anti-osteoporotic drugs (AOD) reduces the risk of fractures and may influence QoL. Objective: ...